BeOne Medicines (NasdaqGS:BGNE) FY Conference Transcript

BeOne Medicines (NasdaqGS:BGNE) FY Conference March 02, 2026 09:10 AM ET Company ParticipantsAaron Rosenberg - CFOMark Lanasa - SVP and Chief Medical Officer of Solid TumorsConference Call ParticipantsJaena Han - AnalystYaron Werber - Managing Director and Senior Biotechnology AnalystYaron WerberAll right. Well, welcome everybody to the 46th annual healthcare conference from TD Cowen here at Boston. I'm Yaron Werber, biotech analyst, along with my colleague, Jaena Han. It's a great pleasure to kick off the ...